Cognition Therapeutics, Inc. (CGTX)

NASDAQ: CGTX · Real-Time Price · USD

1.020

-0.040 (-3.77%)

At close: Aug 28, 2026, 4:00 PM EDT

1.040

+0.020 (1.99%)

After-hours: Aug 28, 2026, 7:59 PM EDT

Cognition Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	34.01	36.81	25.01	29.92	41.56	54.72
Cash & Short-Term Investments	34.01	36.81	25.01	29.92	41.56	54.72
Cash Growth	216.60%	47.19%	-16.42%	-28.01%	-24.05%	954.56%
Other Receivables	2.95	9.92	2.69	1.28	3.67	2.27
Receivables	2.95	9.92	2.69	1.28	3.67	2.27
Prepaid Expenses	0.59	1.07	1.86	3.02	2.41	2.01
Restricted Cash	0.75	0.19	-	-	-	-
Total Current Assets	38.3	47.99	29.56	34.22	47.65	58.99
Property, Plant & Equipment	0.6	0.4	0.68	0.94	1.05	0.15
Other Long-Term Assets	-	-	-	-	1.73	-
Total Assets	38.9	48.39	30.23	35.16	50.43	59.14

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	0.67	1.12	1.98	3.7	3.22	4.17
Accrued Expenses	3.83	12	7.62	4.05	2.09	1.75
Short-Term Debt	0.08	0.31	0.28	0.54	0.63	-
Current Portion of Leases	0.09	0.14	0.19	0.17	0.15	-
Current Unearned Revenue	0.78	0.37	1.07	1.7	1.7	0.75
Other Current Liabilities	-	-	-	-	-	1.19
Total Current Liabilities	5.45	13.92	11.14	10.17	7.8	7.86
Long-Term Leases	0.42	0.2	0.34	0.52	0.7	-
Long-Term Unearned Revenue	-	-	-	-	1.69	-
Total Liabilities	5.87	14.12	11.48	10.69	10.18	7.86

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0.1	0.09	0.06	0.03	0.03	0.02
Additional Paid-In Capital	240.08	232.83	193.85	165.83	155.82	145.45
Retained Earnings	-207.15	-198.65	-175.16	-141.19	-115.4	-94
Comprehensive Income & Other	-	-	-	-0.2	-0.2	-0.2
Total Common Equity	33.02	34.27	18.75	24.47	40.25	51.27
Shareholders' Equity	33.02	34.27	18.75	24.47	40.25	51.27
Total Liabilities & Equity	38.9	48.39	30.23	35.16	50.43	59.14

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	0.59	0.64	0.81	1.24	1.48	-
Net Cash (Debt)	33.42	36.17	24.2	28.68	40.08	54.72
Net Cash Growth	225.28%	49.50%	-15.65%	-28.44%	-26.75%	-
Net Cash Per Share	0.39	0.50	0.61	0.96	1.70	10.54
Filing Date Shares Outstanding	95.09	89.35	61.97	39	29.26	22.58
Total Common Shares Outstanding	95.06	88.9	59.85	32.17	28.99	22.23
Working Capital	32.85	34.07	18.41	24.05	39.85	51.13
Book Value Per Share	0.35	0.39	0.31	0.76	1.39	2.31
Tangible Book Value	33.02	34.27	18.75	24.47	40.25	51.27
Tangible Book Value Per Share	0.35	0.39	0.31	0.76	1.39	2.31
Machinery	-	0.28	1.34	1.33	1.19	1.02

SEC Filings: 10-K · 10-Q